Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy
- DOI
- 10.33320/maced.pharm.bull.2026.72.03.249
- Published
- 10
- Container
- Makedonsko Farmacevtski Bilten
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.33320/maced.pharm.bull.2026.72.03.249,
title = {Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy},
author = {Branka Pashaliska Cvetkov and Ivan Barbov and Dragana Cvetkovska Petrovska and Jasmina Korunoska},
year = {2026},
journal = {Makedonsko Farmacevtski Bilten},
doi = {10.33320/maced.pharm.bull.2026.72.03.249},
url = {https://doi.org/10.33320/maced.pharm.bull.2026.72.03.249}
}RIS
TY - JOUR TI - Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy AU - Branka Pashaliska Cvetkov AU - Ivan Barbov AU - Dragana Cvetkovska Petrovska AU - Jasmina Korunoska PY - 2026 JO - Makedonsko Farmacevtski Bilten DO - 10.33320/maced.pharm.bull.2026.72.03.249 UR - https://doi.org/10.33320/maced.pharm.bull.2026.72.03.249 ER -
APA
Cvetkov, B. P., Barbov, I., Petrovska, D. C., & Korunoska, J. (2026). Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy. Makedonsko Farmacevtski Bilten. https://doi.org/10.33320/maced.pharm.bull.2026.72.03.249
Source records
- doaj · retrieved 2026-09-26T07:15:11.694Z